09. March 2018 The use of amorphous solid dispersions (ASD) to overcome poor drug solubility has gained interest in the pharmaceutical industry over the past decade. ASDs…

19. February 2018 The effects of tablet preparation and subsequent film coating with amorphous solid dispersion (ASD) particles that were composed of a drug with poor water…

26. January 2018 Abstract The understanding of amorphous solid dispersions has grown significantly in the past decade. This is evident from the number of approved commercial amorphous solid dispersion products. While…

11. January 2018 Purpose The oral bioavailability of poorly water-soluble active pharmaceutical ingredients (APIs) can be improved by the preparation of amorphous solid dispersions (ASDs) where the API is…

11. January 2018 This presentation @DDF Summit will cover the following topics: Amorphous solid dispersions Amorphous-amorphous phase separation Solvent…

30. December 2017 Abstract Among the strategies to improve the biopharmaceutic properties of poorly soluble drugs, Supersaturating Drug Delivery Systems like…

24. December 2017 The preparation of amorphous solid dispersions (ASDs) is a well-established strategy for formulating active pharmaceutical ingredients by embedding them in…

09. December 2017 Simulation of HME processes is a valuable tool for increased process understanding and ease of scale-up. However, the experimental determination of all…